These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1133 related items for PubMed ID: 25548122
1. Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study. Akgun I, Unlu MC, Erdal OA, Ogut T, Erturk M, Ovali E, Kantarci F, Caliskan G, Akgun Y. Arch Orthop Trauma Surg; 2015 Feb; 135(2):251-263. PubMed ID: 25548122 [Abstract] [Full Text] [Related]
2. The Effect of Cell Dose on the Early Magnetic Resonance Morphological Outcomes of Autologous Cell Implantation for Articular Cartilage Defects in the Knee: A Randomized Clinical Trial. Niemeyer P, Laute V, John T, Becher C, Diehl P, Kolombe T, Fay J, Siebold R, Niks M, Fickert S, Zinser W. Am J Sports Med; 2016 Aug; 44(8):2005-14. PubMed ID: 27206690 [Abstract] [Full Text] [Related]
3. Microfracture Versus Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Knee: A Systematic Review of 5-Year Outcomes. Kraeutler MJ, Belk JW, Purcell JM, McCarty EC. Am J Sports Med; 2018 Mar; 46(4):995-999. PubMed ID: 28423287 [Abstract] [Full Text] [Related]
4. A Comparison of 2-Year Outcomes in Patients Undergoing Tibiofemoral or Patellofemoral Matrix-Induced Autologous Chondrocyte Implantation. Ebert JR, Schneider A, Fallon M, Wood DJ, Janes GC. Am J Sports Med; 2017 Dec; 45(14):3243-3253. PubMed ID: 28910133 [Abstract] [Full Text] [Related]
5. One-step surgery with multipotent stem cells for the treatment of large full-thickness chondral defects of the knee. Gobbi A, Karnatzikos G, Sankineani SR. Am J Sports Med; 2014 Mar; 42(3):648-57. PubMed ID: 24458240 [Abstract] [Full Text] [Related]
6. Second-look assessment after all-arthroscopic autologous chondrocyte implantation with spheroides at the knee joint. Siebold R, Karidakis G, Feil S, Fernandez F. Knee Surg Sports Traumatol Arthrosc; 2016 May; 24(5):1678-85. PubMed ID: 26704798 [Abstract] [Full Text] [Related]
7. Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: a randomized clinical trial. Zeifang F, Oberle D, Nierhoff C, Richter W, Moradi B, Schmitt H. Am J Sports Med; 2010 May; 38(5):924-33. PubMed ID: 19966102 [Abstract] [Full Text] [Related]
9. Correlation Between Clinical and Radiological Outcomes After Matrix-Induced Autologous Chondrocyte Implantation in the Femoral Condyles. Ebert JR, Smith A, Fallon M, Wood DJ, Ackland TR. Am J Sports Med; 2014 Aug; 42(8):1857-64. PubMed ID: 24890782 [Abstract] [Full Text] [Related]
12. Long-term Clinical Outcomes of One-Stage Cartilage Repair in the Knee With Hyaluronic Acid-Based Scaffold Embedded With Mesenchymal Stem Cells Sourced From Bone Marrow Aspirate Concentrate. Gobbi A, Whyte GP. Am J Sports Med; 2019 Jun; 47(7):1621-1628. PubMed ID: 31095402 [Abstract] [Full Text] [Related]
13. Equivalent 10-Year Outcomes After Implantation of Autologous Bone Marrow-Derived Mesenchymal Stem Cells Versus Autologous Chondrocyte Implantation for Chondral Defects of the Knee. Teo AQA, Wong KL, Shen L, Lim JY, Toh WS, Lee EH, Hui JHP. Am J Sports Med; 2019 Oct; 47(12):2881-2887. PubMed ID: 31433674 [Abstract] [Full Text] [Related]
14. Clinical and radiological long-term outcomes after matrix-induced autologous chondrocyte transplantation: a prospective follow-up at a minimum of 10 years. Aldrian S, Zak L, Wondrasch B, Albrecht C, Stelzeneder B, Binder H, Kovar F, Trattnig S, Marlovits S. Am J Sports Med; 2014 Nov; 42(11):2680-8. PubMed ID: 25204296 [Abstract] [Full Text] [Related]
15. A Prospective Clinical and Radiological Evaluation at 5 Years After Arthroscopic Matrix-Induced Autologous Chondrocyte Implantation. Ebert JR, Fallon M, Wood DJ, Janes GC. Am J Sports Med; 2017 Jan; 45(1):59-69. PubMed ID: 27587741 [Abstract] [Full Text] [Related]
16. Good mid-term outcomes after adipose-derived culture-expanded mesenchymal stem cells implantation in knee focal cartilage defects. Kyriakidis T, Iosifidis M, Michalopoulos E, Melas I, Stavropoulos-Giokas C, Verdonk R. Knee Surg Sports Traumatol Arthrosc; 2020 Feb; 28(2):502-508. PubMed ID: 31493012 [Abstract] [Full Text] [Related]
17. Long-term outcomes after first-generation autologous chondrocyte implantation for cartilage defects of the knee. Niemeyer P, Porichis S, Steinwachs M, Erggelet C, Kreuz PC, Schmal H, Uhl M, Ghanem N, Südkamp NP, Salzmann G. Am J Sports Med; 2014 Jan; 42(1):150-7. PubMed ID: 24145948 [Abstract] [Full Text] [Related]
18. Factors predictive of outcome 5 years after matrix-induced autologous chondrocyte implantation in the tibiofemoral joint. Ebert JR, Smith A, Edwards PK, Hambly K, Wood DJ, Ackland TR. Am J Sports Med; 2013 Jun; 41(6):1245-54. PubMed ID: 23618699 [Abstract] [Full Text] [Related]
19. Cell-Seeded Autologous Chondrocyte Implantation: A Simplified Implantation Technique That Maintains High Clinical Outcomes. Gomoll AH, Ambra LF, Phan A, Mastrocola M, Shah N. Am J Sports Med; 2017 Apr; 45(5):1028-1036. PubMed ID: 28056183 [Abstract] [Full Text] [Related]
20. Results 2 Years After Matrix-Associated Autologous Chondrocyte Transplantation Using the Novocart 3D Scaffold: An Analysis of Clinical and Radiological Data. Zak L, Albrecht C, Wondrasch B, Widhalm H, Vekszler G, Trattnig S, Marlovits S, Aldrian S. Am J Sports Med; 2014 Jul; 42(7):1618-27. PubMed ID: 24817007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]